US 11116843
Conjugated antisense compounds and their use
granted A61KA61K31/7105A61K47/549
Quick answer
US patent 11116843 (Conjugated antisense compounds and their use) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/7105, A61K47/549, A61K47/551, A61K47/554